INOUE BALLOON CATHETER PTMC-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 1997-02-14 for INOUE BALLOON CATHETER PTMC-26 manufactured by Toray Industries, Inc..

Event Text Entries

[45107] During valvuloplasty procedure using balloon catheter, left atrial wall was perforated. Hypotension and pericardial tamponade were noted while operator was manipulating catheter across interatrial septum. Surgical repair was required. Pt has recovered.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2433215-1997-00001
MDR Report Key70006
Report Source05,07
Date Received1997-02-14
Date of Report1997-02-14
Date of Event1996-12-02
Date Mfgr Received1997-01-16
Device Manufacturer Date1995-12-01
Date Added to Maude1997-02-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameINOUE BALLOON CATHETER
Generic NameBALLOON VALVULOPLASTY CATHETER
Product CodeMAD
Date Received1997-02-14
Model NumberPTMC-26
Catalog NumberPTMC-26
Lot Number12-19-1995
ID Number*
Device Expiration Date1997-12-19
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age*
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key69934
ManufacturerTORAY INDUSTRIES, INC.
Manufacturer Address1-1 OE 1-CHOME SETA PLANT OTSU-SHI SHIGA JA 250-21
Baseline Brand NameINOUE BALLOON CATHETER
Baseline Generic NameBALLOON VALVULOPLASTY CATHETER
Baseline Model NoPTMC-26
Baseline Catalog NoPTMC-26
Baseline IDNONE
Baseline Device FamilyINOUE BALLOON CATHETER
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagY
Premarket ApprovalP9100
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention 1997-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.